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Abstract
Purpose : To investigate metabolic byproducts from diabetic
retinopathy by fundus auto uorescence (FAF) lifetime imaging (FLIO)
and to discriminate patients from healthy controls.
Methods : 33 patients su ering from non-proliferative diabetic
retinopathy (NPDR) and 28 age-matched controls were subjected to
retinal  uorescence lifetime measurement using FLIO (Heidelberg
Engineering, Heidelberg, Germany). Auto uorescence of a 30 degree
retinal  eld was excited by picosecond laser pulses (75 ps FWHM) at 468
nm and  uorescence decay over time was recorded in two spectral
channels (498-560nm and 560-720nm). FAF decays were approximated
by a series of three exponential functions (least square  t) in each pixel
of the FAF image resulting in three lifetimes (τ1-τ3), and three respective
amplitudes (a1-a3). Main outcome measure was the amplitude-
weighted mean lifetime τm. All parameters were averaged over the
sub elds of the standard ETDRS-grid centered at the macula.
Results : FAF lifetimes τ1-τ3 as well as tm were extended in the patients
compared to controls (Man-Whitney-U-test, p<0.05,  g. 1). This was
found predominantly in the short-wavelength channel for the inner ring
of the ETDRS-grid: τm=333±141ps vs. 220±79ps (p=0.001). Statistically
independent FLIO-parameters were combined in a logistic regression
model. A sensitivity of 90.1% and a speci city of 71.4% were found for
the discrimination of NPDR-patients (area under the ROC-curve: 0.865).
Conclusions : Independent from other clinical signs of NPDR, FLIO can
hint on diabetic alterations at the posterior pole of the eye. The
extension of  uorescence lifetimes, predominantly at short
wavelengths, may be explained by the accumulation of advanced
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glycation end products which showed long lifetimes in previous in-vitro
investigations peaking at 500 nm. FLIO should be considered as a new
imaging technique capable to detect speci c  uorophores at the fundus
with possible pathognomonic implication.
This is an abstract that was submitted for the 2016 ARVO Annual
Meeting, held in Seattle, Wash., May 1-5, 2016.
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Color-coded mean FAF lifetime (τm) images of a control subject (left)
and a NPDR patient (right).
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